Torque Expands Leadership Team with Appointment of Sok Cheng Soh as CFO and Ana Radeljevic as VP, Head of Business Operations

CAMBRIDGE, Mass., Aug. 22, 2019 -- (Healthcare Sales & Marketing Network) -- Torque, a clinical-stage immuno-oncology company developing Deep-Primed™ T Cell Therapeutics to direct immune power deep within the tumor microenvironment, announced today the ap... Biopharmaceuticals, Oncology, Personnel Torque, Deep-Primed, T Cell Therapeutics
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news